These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35416340)

  • 1. Invasive cervical cancer audit: What lessons can we learn locally and where would we stand with regard to duty of candour?
    Burgess H; Ellis K; Gillespie AM; Macdonald MC; Palmer JE
    Cytopathology; 2022 Sep; 33(5):572-583. PubMed ID: 35416340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of screening episodes linked to CIN3 and invasive cancer registrations to study outcomes from the NHS Cervical Screening Programme.
    Blanks RG; Moss SM; Coleman DA; Addou S; Swerdlow AJ
    Cytopathology; 2009 Jun; 20(3):154-60. PubMed ID: 19207309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Audit of cervical cytology in HIV-positive women.
    Morris EJ; Bates S
    Int J STD AIDS; 2007 Feb; 18(2):126-7. PubMed ID: 17331288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing the national invasive cervical cancer audit: a local perspective.
    Moss EL; Pearmain P; Askew S; Owen G; Reynolds TM; Prabakar IM; Douce G; Parkes J; Menon V; Todd RW; Redman CW
    BJOG; 2010 Oct; 117(11):1411-6. PubMed ID: 20716252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An audit of cervical cytology in HIV-positive women.
    Hotonu OE; Hussey J; Basta MS; Wadehra V; Cross P; Schmid ML
    Cytopathology; 2010 Apr; 21(2):116-9. PubMed ID: 19843141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive cervical cancer audit: why cancers developed in a high-risk population with an organised screening programme.
    Herbert A; Anshu ; Culora G; Dunsmore H; Gupta SS; Holdsworth G; Kubba AA; McLean E; Sim J; Raju KS
    BJOG; 2010 May; 117(6):736-45. PubMed ID: 20184570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of cytology and histopathology as part of the NHS Cervical Screening Programme audit of invasive cervical cancers.
    Castanon A; Ferryman S; Patnick J; Sasieni P
    Cytopathology; 2012 Feb; 23(1):13-22. PubMed ID: 22243289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical squamous cells of undetermined significance: audit and the impact of potential litigation. Retrospective review of 682 cases.
    Scheiden R; Wagener C; Knolle U; Dippel W; Capesius C
    Cytopathology; 2003 Oct; 14(5):257-62. PubMed ID: 14510889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the CervicalCheck controversy on provision of colposcopy services in Ireland: A cohort study.
    Cheung M; Fitzpatrick M
    Eur J Obstet Gynecol Reprod Biol; 2021 Jul; 262():228-231. PubMed ID: 34087721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cytology screening in HIV-positive women: completion of the audit cycle.
    Bates SM; Street EJ
    Int J STD AIDS; 2011 Oct; 22(10):615-6. PubMed ID: 21998191
    [No Abstract]   [Full Text] [Related]  

  • 11. Excess cervical cancer screening smears: Any benefit? A retrospective cohort in Alsace, France.
    Thiery A; Akladios C; Fender M; Severac F; Baldauf JJ
    J Med Screen; 2017 Jun; 24(2):92-97. PubMed ID: 27206814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achievable laboratory standards; a review of cytology of 99 women with cervical cancer.
    Womack C; Warren AY
    Cytopathology; 1998 Jun; 9(3):171-7. PubMed ID: 9638378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
    Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive cervical cancer audit: a relative increase in interval cancers while coverage increased and incidence declined.
    Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
    BJOG; 2009 May; 116(6):845-53. PubMed ID: 19432575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study.
    Rozemeijer K; Naber SK; Penning C; Overbeek LI; Looman CW; de Kok IM; Matthijsse SM; Rebolj M; van Kemenade FJ; van Ballegooijen M
    BMJ; 2017 Feb; 356():j504. PubMed ID: 28196844
    [No Abstract]   [Full Text] [Related]  

  • 17. Intensified screening among high risk women within the organised screening programme for cervical cancer in Finland.
    Kotaniemi-Talonen L; Malila N; Anttila A; Nieminen P; Hakama M
    Acta Oncol; 2011 Jan; 50(1):106-11. PubMed ID: 20560860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
    BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.